Compare CORT & WPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | WPP |
|---|---|---|
| Founded | 1998 | 1985 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 4.0B |
| IPO Year | 2001 | 1996 |
| Metric | CORT | WPP |
|---|---|---|
| Price | $113.91 | $25.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $96.50 | N/A |
| AVG Volume (30 Days) | ★ 723.9K | 317.2K |
| Earning Date | 04-30-2026 | 03-19-2026 |
| Dividend Yield | N/A | ★ 11.68% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $761,407,000.00 | N/A |
| Revenue This Year | $26.08 | N/A |
| Revenue Next Year | $26.98 | $4.32 |
| P/E Ratio | $1,240.22 | ★ $38.96 |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $28.66 | $14.81 |
| 52 Week High | $126.38 | $27.78 |
| Indicator | CORT | WPP |
|---|---|---|
| Relative Strength Index (RSI) | 53.41 | 52.57 |
| Support Level | $77.73 | $17.38 |
| Resistance Level | $124.30 | $27.67 |
| Average True Range (ATR) | 4.53 | 0.59 |
| MACD | -1.66 | -0.41 |
| Stochastic Oscillator | 31.71 | 30.60 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe. WPP is the largest media buying entity in the world.